| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/22/2008 | CA2390685C Methods and compositions for inhibiting neoplastic cell growth |
| 04/22/2008 | CA2265936C Process for producing a plasma protein-containing medicament |
| 04/22/2008 | CA2174737C Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
| 04/22/2008 | CA2112395C Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 04/17/2008 | WO2008045976A2 Compositions and methods for treating and diagnosing cancers |
| 04/17/2008 | WO2008045601A2 Adenovirus-based genetic vaccines for biodefense |
| 04/17/2008 | WO2008045563A2 Modification of ionic strength in antibody-solutions to reduce opalescence/aggregates |
| 04/17/2008 | WO2008045107A2 Botulinum nanoemulsions |
| 04/17/2008 | WO2008044928A1 Complement inhibition for improved nerve regeneration |
| 04/17/2008 | WO2008044824A1 Antibodies to ip-10 for treating bone diseases with bone destruction |
| 04/17/2008 | WO2008044787A1 Composition for treating cancer using dref as molecular target |
| 04/17/2008 | WO2008044782A2 Combination drug |
| 04/17/2008 | WO2008044754A1 Prophylactic or therapeutic agent for cancer |
| 04/17/2008 | WO2008044611A1 Ipv-dpt vaccine |
| 04/17/2008 | WO2008044465A1 Method of utilizing thrombin as adjuvant |
| 04/17/2008 | WO2008044149A2 Shigella ipad protein and its use as a vaccine against shigella infection |
| 04/17/2008 | WO2008044076A2 Therapy targeting cathepsin s |
| 04/17/2008 | WO2008044068A2 Combination therapy |
| 04/17/2008 | WO2008043777A1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 04/17/2008 | WO2008043774A1 Vaccine comprising an oil in water emulsion adjuvant |
| 04/17/2008 | WO2008043576A1 Use of oncolytic viruses and antiangiogenic agents in the treatment of cancer |
| 04/17/2008 | WO2008043180A1 Immunostimulatory composition comprising recombinant bcg mycobacterium expressing mammalian cysteine protease |
| 04/17/2008 | WO2008043157A1 Compositions and methods for modulating immune responses |
| 04/17/2008 | WO2008025848A3 Composition for eliciting a specific ctl response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells |
| 04/17/2008 | WO2008024427A3 A virus-like platform for rapid vaccine discovery |
| 04/17/2008 | WO2008024299A3 Combination with bis(thiohydrazide amides) for treating cancer |
| 04/17/2008 | WO2008019888A3 Pax2 and pax8 as targets for immunologic and molecular tumour treatment strategies |
| 04/17/2008 | WO2008019162A9 Compositions and methods related to staphylococcal bacterium proteins |
| 04/17/2008 | WO2008017636A3 Genes and proteins of brachyspira hyodysenteriae and uses thereof |
| 04/17/2008 | WO2008015480A3 Composition and method for modulating an immune response |
| 04/17/2008 | WO2008012031A3 Blockers of gsk3 for the prevention and treatment of pemphigus vulgaris |
| 04/17/2008 | WO2008003748A3 Cd300lg polypeptides and their use in treating autoimmune diseases |
| 04/17/2008 | WO2007144317A3 Vaccine |
| 04/17/2008 | WO2007127951A3 Compositions and methods involving mda-7 for the treatment of cancer |
| 04/17/2008 | WO2007103470A3 Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 04/17/2008 | WO2007095338A3 Functional antibodies |
| 04/17/2008 | WO2007084764A8 Selective activation of protoxins through combinatorial targeting |
| 04/17/2008 | WO2007070629A3 Porphyromonas gingivalis 1435/1449 lps as an immune modulator |
| 04/17/2008 | WO2006071989A9 Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes |
| 04/17/2008 | US20080090996 Thrombopoietin mimetics |
| 04/17/2008 | US20080090994 Novel Antigen Constructs Useful In the Detection and Differentiation of Antibodies to HIV |
| 04/17/2008 | US20080090787 Thrombopoietin mimetics |
| 04/17/2008 | US20080090752 Anti-tumor vasculature effects of human serum albumin derivatives |
| 04/17/2008 | US20080090290 Nucleic Acids Encoding Anti-IL-12 Antibodies, and Methods of Production |
| 04/17/2008 | US20080090281 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 04/17/2008 | US20080090270 Neuronal binding protein for use tool in identifying modulators for prevention and treatment of nervous system disorders |
| 04/17/2008 | US20080090245 Diagnosing and Treating Hematopoietic Cancers |
| 04/17/2008 | US20080090226 Novel Antigen Constructs Useful In the Detection and Differentiation of Antibodies to HIV |
| 04/17/2008 | US20080089931 EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders |
| 04/17/2008 | US20080089929 Immunogenic fusion comprising transcription and negative factor domains for use in generation vaccine for prevention and treatment of viral infections; immunostimulants |
| 04/17/2008 | US20080089923 Biodegradable ocular implants and methods for treating ocular conditions |
| 04/17/2008 | US20080089911 Borrelia burgdorferi outer surface protein ( OSP)C antigen and a second antigenic lipoprotein such as genetic engineered OSPA, or streptococcus pneumoniae cell surface protein ( PSPA) or both in same physio-chemical |
| 04/17/2008 | US20080089910 Attenuated Herpes Simplex Virus Type-2, Vectors Thereof and Immunogenic Compositions Thereof |
| 04/17/2008 | US20080089909 nucleotide sequences encoding HIV-1 Clade A Gag, Pol (RT and Int), and Nef ("GRIN), HIV-1 Clade A Gag, RT and Nef ("GRN") or HIV-1 Clade A Env; generating an immune response against HIV-1 |
| 04/17/2008 | US20080089908 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 04/17/2008 | US20080089907 Modified vaccinia Ankara virus variant |
| 04/17/2008 | US20080089904 Clostridium toxin, and process for the preparation of immunogenic composition |
| 04/17/2008 | US20080089903 Cd4+t-lymphocyte-specific hepatitis c virus epitopes |
| 04/17/2008 | US20080089902 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 04/17/2008 | US20080089900 Identification of self and non-self antigens implicated in autoimmune disease |
| 04/17/2008 | US20080089899 Streptococcus pneumoniae proteins and nucleic |
| 04/17/2008 | US20080089898 Immunotoxins directed against CD33 related surface antigens |
| 04/17/2008 | US20080089897 ActRIIB Fusion Polypeptides and Uses Therefor |
| 04/17/2008 | US20080089896 Bivalent SMAC mimetics and the uses thereof |
| 04/17/2008 | US20080089895 Using antisense agents specific to lymphocyte membrane protein (TIRC7) as therapeutic tools in treatment and prevention of cell proliferative, vision and ischemic heart defects; wound healing agents |
| 04/17/2008 | US20080089894 Transplant tolerance by costimulation blockade and T-cell activation-induced apoptosis |
| 04/17/2008 | US20080089893 therapeutic strategies which include the use of administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies, and cooperative strategies comprising the use of chimeric anti-CD20 antibodies and radiolabeled anti-CD20 antibodies; Anticancer agent |
| 04/17/2008 | US20080089892 Fc Region Variants |
| 04/17/2008 | US20080089891 Cancerous disease modifying antibodies |
| 04/17/2008 | US20080089890 Methods of polypeptide production |
| 04/17/2008 | US20080089889 Novel Bone Metastasis Marker Peptide and Method of Diagnosing Bone Metastasis by Using the Same |
| 04/17/2008 | US20080089888 Nucleotide sequences coding cancer/testis antigen for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 04/17/2008 | US20080089887 Members of the FC Receptor Homolog Gene Family (FcRH1-3,6) Related Reagents and Uses Thereof |
| 04/17/2008 | US20080089886 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/17/2008 | US20080089885 Anti-cd20 antibodies and methods of use |
| 04/17/2008 | US20080089884 For treating and/or preventing bladder disorders; for decreasing the expression, release or biological activity of macrophage migration inhibition factor |
| 04/17/2008 | US20080089883 Antisense oligonucleotides for prevention and/or treatment of infection, asthma, skin, inflammatory and/or autoimmune disorders |
| 04/17/2008 | US20080089882 Novel Polypeptide Useful for Cancer Diagnosis and Treatment |
| 04/17/2008 | US20080089881 Using nicotinic acid receptor (HM74) as diagnostic and evaluative tool in detection of psoraisis, ulcerative colitis, multiple sclerosis, irratable bowel and/or , crohn's diseases |
| 04/17/2008 | US20080089869 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 04/17/2008 | US20080089863 Non-Integrative And Non-Replicative Lentivirus , Preparation And Uses Thereof |
| 04/17/2008 | US20080089861 Therapeutic agent comprising memantine and dimethyl fumarate for use in prevention and treatment of autoimmune and nervous system disorders |
| 04/17/2008 | US20080089859 Administration of sleep restorative agents |
| 04/17/2008 | US20080089849 Powders for inhalation |
| 04/17/2008 | US20080089838 antibody binds target tissue and conjugate carrying epitope (haptens); monoclonal antibody or fragment thereof binds to a colon-specific antigen-p mucin (CSAp) antigen - the Mu-9 epitope; DNA sequence; anticancer |
| 04/17/2008 | US20080089837 monoclonal antibodies directed to the antigen Platelet derived growth factor-alpha |
| 04/17/2008 | CA2703466A1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 04/17/2008 | CA2702340A1 Compositions and methods for modulating immune responses |
| 04/17/2008 | CA2683122A1 Therapy targeting cathepsin s |
| 04/17/2008 | CA2666563A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 04/17/2008 | CA2666466A1 Complement inhibition for improved nerve regeneration |
| 04/17/2008 | CA2666249A1 Agent for preventing/treating cancer |
| 04/17/2008 | CA2666184A1 The use of a dna damaging agent and a ligand for the treatment of cancer |
| 04/17/2008 | CA2665943A1 Shigella ipad protein and its use as a vaccine against shigella infection |
| 04/17/2008 | CA2665568A1 Preparation of inactivated artificial antigen presenting cells and their use in cell therapies |
| 04/17/2008 | CA2665423A1 Methods and compositions with reduced opalescence |
| 04/17/2008 | CA2665068A1 Methods for treating cancer with mva |
| 04/17/2008 | CA2664799A1 Ipv-dpt vaccine |
| 04/17/2008 | CA2631927A1 Botulinum nanoemulsions |
| 04/16/2008 | EP1911765A2 Prevention, treatment and diagnosis of diseases associated with Beta-Amyloid formation and/or aggregation |